Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
delisting
MedTech
PAVmed staves off Nasdaq delisting as net loss widens
After its allotted six months to regain compliance with the Nasdaq’s listing rules passed by without success, PAVmed has bought a bit of extra time.
Andrea Park
Jun 29, 2023 1:29pm
Why do so many biotechs face being kicked off the Nasdaq?
Mar 14, 2023 9:55am
Nasdaq delists Titan Medical amid mass layoffs, failed sale
Mar 9, 2023 1:59pm
Titan Medical lays off 70% of staff as attempted sale fails
Feb 10, 2023 9:50am
Rockley Photonics files for bankruptcy
Jan 26, 2023 12:21pm
Titan Medical furloughs 40 employees amid strategic review
Dec 7, 2022 11:56am